Latest News Archive

Please select Category, Year, and then Month to display items

Agreement between UFS rectorate and Institutional Student Representative Council (ISRC) on 16 March 2021

16 March 2021 | Story Lacea Loader

UPDATE: 16 March 2021 at 20:37

During a meeting between members of the Rectorate and representatives of the Institutional Student Representative Council (ISRC) on 15 and 16 March 2021, the following was agreed upon:

1. SUSPENSION OF THE ACADEMIC PROGRAMME

All academic activities have been suspended on all UFS campuses from 17 to 22 March 2021. No online/face-to-face lectures/tests/assignments will take place until 23 March 2021, and the full academic programme will resume on this date.

This decision will allow the university management an opportunity to address outstanding matters regarding the admission of senior undergraduate students.

2. FACE-TO-FACE REGISTRATION

Any senior undergraduate and first-year student who is unable to register successfully online, can do so on the Bloemfontein and Qwaqwa Campuses from 17 to 19 March 2021.

► Registration stations:

Bloemfontein Campus:

- Examination Centre (EXR)

Qwaqwa Campus:

- Faculty of Education: Mandela Hall
- Faculty of the Humanities: E0013 + 14
- Faculty of Economic and Management Sciences: E009 + 10 – EMS
- Faculty of Natural and Agricultural Sciences: Fulufhelo Gazelle

► Operating times on both campuses:

17 March 2021: 13:00-15:00
18 and 19 March 2021: 8:00-15:00

The following must be noted:

Senior undergraduate students must be in possession of a valid student card (previous year) and will be allowed to enter the campuses without an access permit in order to register.

First-year students must be in possession of a firm offer from the UFS in order to register – no campus access permit is needed.

3. NUMBER OF STUDENTS ON CAMPUSES

The university management is aware of the challenges that some students are experiencing with the continuation of their studies off campus in terms of, for instance, access to campus facilities and connectivity.

It is, however, important to take note that the institution is obliged to adhere to national regulations linked to Level 1 of the national lockdown, also taking into account the university’s teaching and learning approach, as well as the capacity to adhere to physical distancing protocols.

The university management will continue with the return of students to the campuses in a responsible way, as the safety, health, and well-being of students and staff remain the key priorities.

With this in mind, the university will reconsider its blended learning arrangements for 2021 to allow more students to return to campus within the parameters of the national lockdown regulations. These arrangements will be communicated to students soon.

4. ACADEMICALLY ELIGIBLE STUDENTS

The university will compile a list of students who have outstanding debt and who are still awaiting funding confirmation from NSFAS. Confirmation will be provided before midnight on 16 March 2021 if these students can register provisionally without payment of the first amount.

5. MEAL ALLOWANCES

The payment of meal allowances for NSFAS students will be implemented by the end of March 2021. It should be noted that NSFAS is only expected to transfer funds in April, but the UFS will lay out the funds for food allowances in the meantime.

6. ACADEMIC EXCLUSION

During the meetings on 15 and 16 March 2021, the ISRC tabled the matter regarding students who are academically excluded for the 2021 academic year. This matter is being addressed by the university management and engagement in this regard will continue.

7. VICTIMISATION OF STUDENTS BY PRIVATE SECURITY

During the meetings on 15 and 16 March 2021, the ISRC tabled the matter regarding students being victimised, harassed, and assaulted by private security.

The ISRC will submit more information, after which the allegations will be investigated.

Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393

News Archive

Nuclear Medicine on the forefront of cancer research

2017-07-10

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma. The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept